awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33990855-4DEE3575-0F96-44EF-92AA-E27791412C56
Q33990855-4DEE3575-0F96-44EF-92AA-E27791412C56
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33990855-4DEE3575-0F96-44EF-92AA-E27791412C56
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr
P2860
Q33990855-4DEE3575-0F96-44EF-92AA-E27791412C56
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33990855-4DEE3575-0F96-44EF-92AA-E27791412C56
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c57ab7cd91fe38584d23123dd1d9d8ee952fc8d5
P2860
Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.